CAD031
CAD031 is an orally active AMPK/ACC1 signaling pathway activator and a derivative of the Alzheimer's disease (AD) targeted agent J147 (more active than J147 in human neural stem cell assays). CAD031 can cross the blood-brain barrier, activate AMPK and inhibit ACC1, thereby increasing ac-CoA levels, improving mitochondrial function and reducing free fatty acid synthesis. CAD031 has neuroprotective, neurogenesis-promoting and memory-improving activities and can be used in the study of Alzheimer's disease and aging-related neurodegenerative diseases. CAD031 effectively enhances the memory of mice, improves dendritic structure, and stimulates cell division in the germinal zone of the brain of elderly mice[1][2][3].
Product Specifications
CAS Number
2071209-49-7
UNSPSC
12352005
Target
Acetyl-CoA Carboxylase; AMPK
Type
Reference compound
Related Pathways
Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cad031.html
Purity
99.39
Solubility
DMSO : 100 mg/mL (ultrasonic; warming)
Smiles
O=C(N(C1=CC=C(C)C=C1C)/N=C/C2=CC=CC(OC(F)(F)F)=C2)C(F)(F)F
Molecular Formula
C18H14F6N2O2
Molecular Weight
404.31
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (R1/69), CF640R conjugate, 0.1mg/mL
MSH2 (DNA Mismatch Repair Marker) (MSH2/2622), CF740 conjugate, 0.1mg/mL
